Buprenorphine (Suboxone and others) is an effective medication for treating patients with opioid addiction. Research has shown that it works better than standard psychosocial or “abstinence-based” treatments. But is the cost of the drug worth the extra therapeutic benefit?
New technology has brought with it a new addiction. Clinicians may now face the challenge of how to treat the growing problem of internet addiction, where patients experience online-related, compulsive behaviors that interfere with daily life, work, and relationships.
Naltrexone, which first hit the US market in 1984 as a treatment for alcohol dependence, continues to find new uses. Its latest incarnation, Contrave, was just approved by the Food and Drug Administration (FDA) in September as a weight loss medication.
A new report from the Centers for Disease Control and Prevention (CDC) says that in adults ages 20 to 64, one in 10 deaths are the result of excessive drinking.
In this modern era of neuroscience, how can we take seriously the notion that an effective way to address the chronically relapsing brain disease of addiction is by recommending that those affected congregate frequently in rented church basements to discuss their addiction and recovery experiences?
Alcoholics Anonymous (AA) and its 12-step cousins are the oldest, best known, and most widely available recovery support groups. In recent decades, however, a number of alternatives have appeared that may be better suited for some people in recovery.
Alcoholics Anonymous (AA) occupies such a prominent place in popular culture and addiction treatment that it seems a little odd to question its effectiveness. But odd, counterintuitive questions about AA have been accumulating for years, and we finally have a book that collects them all in one place.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available...